Literature DB >> 8111410

Mutations of the APC (adenomatous polyposis coli) gene.

H Nagase1, Y Nakamura.   

Abstract

Several investigators have reported germline mutations of the APC gene in patients with familial adenomatous polyposis (FAP) as well as somatic mutations in tumors developed in digestive organs (stomach, pancreas, colon, and rectum). Those results provide evidence that inactivation of the APC gene plays a significant role in FAP and in sporadic tumors of these tissues. APC mutations have led to some interesting observations. First, the great majority of the mutations found to date would result in truncation of the APC product. Second, almost all the mutations have occurred within the first half of the coding sequence, and somatic mutations in colorectal tumors are further clustered in a particular region called MCR (mutation cluster region). Third, most identified point mutations in the APC gene are transitions from cytosine to other nucleotides. Fourth, the location of germ-line mutations tends to correlate with the number of colorectal polyps in FAP patients. Furthermore, inactivation of both alleles of the APC gene seems to be required as an early event to develop most of adenomas and carcinomas in the colon and rectum as well as some of those in the stomach.

Entities:  

Mesh:

Year:  1993        PMID: 8111410     DOI: 10.1002/humu.1380020602

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  86 in total

1.  Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

Authors:  Manjinder Kaur; Balaiya Velmurugan; Alpna Tyagi; Chapla Agarwal; Rana P Singh; Rajesh Agarwal
Journal:  Neoplasia       Date:  2010-05       Impact factor: 5.715

2.  Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein.

Authors:  W Friedl; S Meuschel; R Caspari; C Lamberti; S Krieger; M Sengteller; P Propping
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers.

Authors:  Koh Furuta; Shingo Yoshioka; Satoko Okabe; Masato Ikeda; Mihoko Oginosawa; Seiyo Ikeda; Yoshifuku Nakayama; Masahiro Kikuchi; Stanley R Hamilton
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

4.  The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.

Authors:  I M Frayling; N E Beck; M Ilyas; I Dove-Edwin; P Goodman; K Pack; J A Bell; C B Williams; S V Hodgson; H J Thomas; I C Talbot; W F Bodmer; I P Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

5.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

6.  Extracolonic manifestations of hereditary colorectal cancer syndromes.

Authors:  Daniel A Anaya; George J Chang; Miguel A Rodriguez-Bigas
Journal:  Clin Colon Rectal Surg       Date:  2008-11

7.  Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.

Authors:  K Heinimann; B Müllhaupt; W Weber; M Attenhofer; R J Scott; M Fried; S Martinoli; H Müller; Z Dobbie
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

8.  Evolutionary dynamics of tumor suppressor gene inactivation.

Authors:  Martin A Nowak; Franziska Michor; Natalia L Komarova; Yoh Iwasa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

9.  Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

Authors:  S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

10.  APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations.

Authors:  Per Arne Andresen; Ketil Heimdal; Kristin Aaberg; Katrine Eklo; Kristin Eklo; Sarah Ariansen; Alexandra Silye; Olav Fausa; Lars Aabakken; Stefan Aretz; Tor J Eide; Tobias Gedde-Dahl
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.